News
The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.
Search for other works by this author on: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback